HTG Molecular Diagnostics' Convertible Note - II Round

HTG Molecular Diagnostics raised a round of funding on December 29, 2006.

HTG Molecular Diagnostics provides simple, cost effective solutions for accurate RNA testing. In 2013 the company commercialized its Edge instrument platform and a portfolio of mRNA assays that levera…

Articles about HTG Molecular Diagnostics' Convertible Note - II Round: